Durvalumab With Chemotherapy as First Line Treatment in Patients With Advanced Biliary Tract Cancers (aBTCs)

计划入组 142 人 · 首次发布于 2023 年 3 月 16 日

Patiromer With or Without Food for the Treatment of Hyperkalemia

计划入组 114 人 · 首次发布于 2016 年 2 月 29 日

Tourmaline Bio

United States

Tourmaline Bio Advances Pacibekitug Program with Expanded Cardiovascular Focus

Novartis Acquires Tourmaline Bio for $1.4 Billion to Advance Anti-Inflammatory Cardiovascular Therapy

Novartis Acquires Tourmaline Bio for $1.4 Billion to Strengthen Cardiovascular Pipeline with Pacibekitug